We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

These Immune Players Deserve More Time in the Limelight

News   Sep 21, 2018 | By Heather Buschman, PhD for UC San Diego Health

 
Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

Major Histocompatibility Complex (MHC) molecules display antigens to T cells, immune cells that constantly check for infected or damaged cells. If T cells spot MHC molecules with foreign antigens or mutated self-antigens (such as cancer antigens), they kill the cell before the damage spreads. MHC-II is only displayed by professional immune cells, such as macrophages, and is recognized by CD4+ T cells. MHC-I is displayed on the surface of every cell, and thus any cell with the potential to become cancerous, and is recognized by CD8+ T cells. Credit: UC San Diego Health

 
 
 

RELATED ARTICLES

Natural Plant Defense Genes

News

In a new study, researchers identify genes and metabolic pathways responsible for safener efficacy in grain sorghum.

READ MORE

Cancer-related Concerns of Thermally-abused Frying Oil Examined

News

Each time dietary oils are heated to deep-frying temperatures, chemical modifications result in a new matrix of lipid structures with potential deleterious health effects. This relationship was examined in mouse models using in vivo bioluminescent imaging.

READ MORE

A New Perspective on Immune and Blood Cell Production

News

Tracking and quantifying the production of different kinds of blood cells and immune cells has provided new insights on how the body maintains a balanced supply.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE